Comments on "dynamic 18F-FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non-small cell lung cancer"

被引：0
|
作者：
Wang, Shan-Ying [1 ,2 ]
Shiau, Yu-Chien [1 ]
Hsu, Chen-Xiong [2 ,3 ]
机构：
[1] Far Eastern Mem Hosp, Dept Nucl Med, New Taipei, Taiwan
[2] Natl Yang Ming Chiao Tung Univ, Dept Biomed Imaging & Radiol Sci, Taipei, Taiwan
[3] Far Eastern Mem Hosp, Dept Radiol, Div Radiat Oncol, New Taipei 220, Taiwan
来源：
THORACIC CANCER | 2022年 / 13卷 / 24期
关键词：
18F-FDG PET/CT; volume-based metabolic parameters; SUV; metabolic tumor volume; total lesion glycolysis;
D O I：
10.1111/1759-7714.14710
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3513 / 3514
页数：2
相关论文
共 50 条
  • [1] Dynamic 18F-FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non-small cell lung cancer
    Chen, Zhi-Yong
    Fu, Rui
    Tan, Xiao-Yue
    Yan, Li-Xu
    Tang, Wen-Fang
    Qiu, Zhen-Bin
    Qi, Yi-Fan
    Li, Yu-Fa
    Hou, Qing-Yi
    Wu, Yi-Long
    Zhong, Wen-Zhao
    Jiang, Ben-Yuan
    THORACIC CANCER, 2022, 13 (17) : 2524 - 2531
  • [2] The prediction of response to immunotherapy in non-small cell lung cancer patients by 18F-FDG PET/CT
    Evangelista, Laura
    JOURNAL OF THORACIC DISEASE, 2019, 11 (11) : E221 - E223
  • [3] Radiomics based on 18F-FDG PET/CT for prediction of pathological complete response to neoadjuvant therapy in non-small cell lung cancer
    Liu, Jianjing
    Sui, Chunxiao
    Bian, Haiman
    Li, Yue
    Wang, Ziyang
    Fu, Jie
    Qi, Lisha
    Chen, Kun
    Xu, Wengui
    Li, Xiaofeng
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [4] Original Utility of 18F-FDG uptake in predicting major pathological response to neoadjuvant immunotherapy in patients with resectable non-small cell lung cancer
    Chen, Xiaowei
    Bai, Guangyu
    Zang, Ruochuan
    Song, Peng
    Bie, Fenglong
    Huai, Qilin
    Li, Yuan
    Liu, Yang
    Zhou, Bolun
    Bie, Yifan
    Yang, Zhenlin
    Gao, Shugeng
    TRANSLATIONAL ONCOLOGY, 2023, 35
  • [5] Evaluation of gross tumor size using CT, 18F-FDG PET, integrated 18F-FDG PET/CT and pathological analysis in non-small cell lung cancer
    Yu, Hui Ming
    Liu, Yun Fang
    Hou, Ming
    Liu, Jie
    Li, Xiao Nan
    Yu, Jin Ming
    EUROPEAN JOURNAL OF RADIOLOGY, 2009, 72 (01) : 104 - 113
  • [6] Baseline 18F-FDG PET/CT parameters in predicting the efficacy of immunotherapy in non-small cell lung cancer
    Zheng, Lu
    Bian, Yanzhu
    Hu, Yujing
    Tian, Congna
    Zhang, Xinchao
    Li, Shuheng
    Yang, Xin
    Qin, Yanan
    FRONTIERS IN MEDICINE, 2025, 12
  • [7] Potentials of Non-Invasive 18F-FDG PET/CT in Immunotherapy Prediction for Non-Small Cell Lung Cancer
    Liao, Xuhe
    Liu, Meng
    Wang, Rongfu
    Zhang, Jianhua
    FRONTIERS IN GENETICS, 2022, 12
  • [8] Role of 18F-FDG PET in Assessment of Response in Non-Small Cell Lung Cancer
    Hicks, Rodney J.
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50 : 31S - 42S
  • [9] Prospective comparison of 18F-FDG PET/MRI and 18F-FDG PET/CT for thoracic staging of non-small cell lung cancer
    Julian Kirchner
    Lino M. Sawicki
    Felix Nensa
    Benedikt M. Schaarschmidt
    Henning Reis
    Marc Ingenwerth
    Simon Bogner
    Clemens Aigner
    Christian Buchbender
    Lale Umutlu
    Gerald Antoch
    Ken Herrmann
    Philipp Heusch
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 437 - 445
  • [10] Prospective comparison of 18F-FDG PET/MRI and 18F-FDG PET/CT for thoracic staging of non-small cell lung cancer
    Kirchner, Julian
    Sawicki, Lino M.
    Nensa, Felix
    Schaarschmidt, Benedikt M.
    Reis, Henning
    Ingenwerth, Marc
    Bogner, Simon
    Aigner, Clemens
    Buchbender, Christian
    Umutlu, Lale
    Antoch, Gerald
    Herrmann, Ken
    Heusch, Philipp
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (02) : 437 - 445
12345